In The News Posted October 7, 2021 Share Posted October 7, 2021 SAN JOSE, Calif. and LAS VEGAS, Oct. 7, 2021 /PRNewswire/ -- LimFlow SA, the pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), on Wednesday announced 24-month results...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts